Janus Henderson Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,099,328
| Closed | -$166M | – | 2664 |
|
|
2022
Q3 | $166M | Buy |
1,099,328
+23,862
| +2% | +$3.61M | 0.06% | 262 |
|
|
2022
Q2 | $157M | Sell |
1,075,466
-1,630,686
| -60% | -$238M | 0.11% | 193 |
|
|
2022
Q1 | $321M | Buy |
2,706,152
+1,299,597
| +92% | +$154M | 0.15% | 155 |
|
|
2021
Q4 | $194M | Buy |
1,406,555
+641,180
| +84% | +$88.4M | 0.08% | 237 |
|
|
2021
Q3 | $106M | Buy |
765,375
+27,480
| +4% | +$3.82M | 0.05% | 349 |
|
|
2021
Q2 | $71.6M | Buy |
737,895
+19,855
| +3% | +$1.93M | 0.03% | 464 |
|
|
2021
Q1 | $49.1M | Buy |
+718,040
| New | +$49.1M | 0.02% | 555 |
|
|
2019
Q2 | – | Sell |
-1,251,607
| Closed | -$64.4M | – | 1442 |
|
|
2019
Q1 | $64.4M | Sell |
1,251,607
-1,892,151
| -60% | -$97.4M | 0.04% | 514 |
|
|
2018
Q4 | $116M | Sell |
3,143,758
-193,158
| -6% | -$7.14M | 0.07% | 308 |
|
|
2018
Q3 | $125M | Buy |
3,336,916
+37,616
| +1% | +$1.41M | 0.07% | 335 |
|
|
2018
Q2 | $130M | Sell |
3,299,300
-96,830
| -3% | -$3.83M | 0.07% | 318 |
|
|
2018
Q1 | $87.5M | Buy |
3,396,130
+2,416,021
| +247% | +$62.2M | 0.05% | 403 |
|
|
2017
Q4 | $26.4M | Buy |
980,109
+291,200
| +42% | +$7.86M | 0.02% | 686 |
|
|
2017
Q3 | $25.8M | Buy |
688,909
+43,166
| +7% | +$1.61M | 0.02% | 680 |
|
|
2017
Q2 | $16.1M | Buy |
+645,743
| New | +$16.1M | 0.01% | 785 |
|